GREGORY D PERRY
CIK 1236371 · Chief Financial Officer & PFO · last filed 2025-12-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$35.1K
Companies
8
Total Filings
63
Lifetime Open-Market Net
-$953.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Merus N.V. (MRUS) Delisted | Chief Financial Officer & PFO | — | $90.00 | — | $0 | 8 | 2025-12-12 |
| KALA | Director | 13,344 | $2.63 | $35.1K | $0 | 9 | 2025-06-17 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Chief Financial Officer | — | $7.30 | — | $0 | 1 | 2022-02-28 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | See Remarks | 1,683 | — | — | $0 | 2 | 2017-05-11 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | See Remarks | — | — | — | $0 | 5 | 2016-11-30 |
| Ocata Therapeutics, Inc. (OCAT) Delisted | Director | 0 | — | — | $0 | 7 | 2016-02-11 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Chief Financial and Business | — | — | — | $0 | 1 | 2015-02-27 |
| ImmunoGen, Inc. (IMGN) Delisted | Chief Financial Officer | 18,337 | $31.23 | $572.7K | -$953.6K | 14 | 2013-09-11 |
Recent Filings · Page 3 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-27 | NOVELION THERAPEUTICS INC. (NVLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-01 | — | Grant (A) | — | $0 | |
| 2016-11-30 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2016-05-11 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-17 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-11 | Ocata Therapeutics, Inc. (OCAT) Delisted | Mixed | −21,417 | -$182.0K | EDGAR |
| 2016-01-04 | Ocata Therapeutics, Inc. (OCAT) Delisted | Grant (A) | +1,250 | $0 | EDGAR |
| 2015-10-01 | Ocata Therapeutics, Inc. (OCAT) Delisted | Grant (A) | +1,250 | $0 | EDGAR |
| 2015-08-06 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-04 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.